Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class ASSE: 600513

"Jiangsu Lianhuan Pharmaceutical Co., Ltd."Semi-annual Report for 2026

Aug 29, 2026 · Issued by Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Semi-annual Report for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A

"Jiangsu Lianhuan Pharmaceutical Co., Ltd."Announcement on the Addition of a Related Party Not Under Common Control and Increase of the Estimated Amount of Routine Related Party Transactions for 2026Aug 25
"Jiangsu Lianhuan Pharmaceutical Co., Ltd."Announcement on Resolutions of the 26th Extraordinary Meeting of the 9th Board of DirectorsAug 12
"Jiangsu Lianhuan Pharmaceutical Co., Ltd."Announcement on Obtaining Drug Registration CertificateAug 8
"Jiangsu Lianhuan Pharmaceutical Co., Ltd."Announcement on the Proposed Selection of the Company and Controlled Subsidiary in the 12th Batch of National Centralized Drug ProcurementAug 4

All Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A news releases